Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
NYSE:PFE
Pfizer Inc (PFE)
26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
Financials 
Technical Analysis 0
COMMENT
Pharma as an industry as a model is really at a crossroads. The chemical-based side is giving way to the biology-side of science. They have a lot of money, but do not have a good pipeline. The biology side is just the opposite. They have the largest phase 2 pipeline that they've ever had and that could translate by 2009 into the biggest phase 3. They own some, but are tempted to pull the plug.
Gordon ReidOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Past Top Pick. Dec 5/06. Down 4.8%.) 5% yield is why he still likes it. All of the bad news is basically known. Sold their consumer products division for $19 billion and will use the cash for acquisitions, share buybacks, dividend increases and increase research. Recession resistant.
Norman LevineOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick Dec 26/06. Down 12.6%.) Still undervalued. Hopefully there’s pressure on management to do something. His model price is $38.27. a 68.5% positive differential.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
(All 3 Top Picks are defensive, have good dividends, solid earnings and limited downside.) 5% yield and will probably raise the dividend. About $19 billion cash for acquisitions. Drugs that are coming off patent is already built into the stock.
Norman LevineOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick Dec 21/06. Down 5.6%.) The model price is $42.64, giving it a 73% positive differential.
Brian Acker, CAOwned
biotechnologypharmaceutical
BUY
Trading at a very attractive multiple (less then 10X next years earnings), 4.5% dividends. They have a lot of things going on in the pipeline. Must be patient with this though.
Gordon ReidOwned
biotechnologypharmaceutical
TOP PICK
His model price is $42.32 a positive 66% differential. Until they read off their goodwill, the stock will probably be in the doghouse for a while.
Brian Acker, CAOwned
biotechnologypharmaceutical
BUY
This is a value stock. A number of its drugs have either come off patent or will be in the next 2, 3 years. On the other hand, it has a strong research/development pipeline and about $19 billion in cash. Cash will be used to raise the dividends, buy back
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
You are getting almost 5% yield while waiting for their pipeline to improve. All the bad news about drugs coming off of patent is out now. Have a huge cash horde that they will use at the right time to acquire companies with promising drugs.
Norman LevineOwned
biotechnologypharmaceutical
BUY
His model price is $39.86, a 61% positive differential. In his top 10. The one consolation on this is that you get a 5% dividend while you wait. Hopes they will write off a lot of their Pharmacia acquisition. Until they do, he doesn't expect much movement.
Brian Acker, CAOwned
biotechnologypharmaceutical
BUY
Corrected partly because of the market and also its latest earnings report was somewhat disappointing even though the company advised that the full year and next year's earnings are expected to be as they previously stated. Almost 5% yield, which totally limits downside risk in the stock. On a market turn around, this will be a major participant.
Norman LevineOwned
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
